#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18040	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2671	832.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1629	1629	C	1095	C,T,G	1092,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30218	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4150	909.0	0	.	n	.	0	T695C	SNP	695	695	T	1380	1380	C	1115	C,T,G	1110,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30218	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4150	909.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	2022	2022	A	1217	A	1217	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30218	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4150	909.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2656	2656	C	1069	C,G,A	1066,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30218	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4150	909.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2730	2730	A	1005	A	1005	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30218	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4150	909.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3282	3282	C	1082	C,A	1080,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2620	folP	855	855	100.0	folP.l15.c4.ctg.1	2106	155.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1320	1322	AGC	290;287;286	A;G,T;C	290;286,1;286	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3901	204.0	1	SNP	p	S91F	1	.	.	271	273	TTC	836	838	TTC	240;238;238	T;T;C	240;238;238	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3901	204.0	1	SNP	p	G95N	0	.	.	283	285	GGC	848	850	GGC	241;241;244	G;G;C	241;241;244	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3901	204.0	1	SNP	p	D95G	1	.	.	283	285	GGC	848	850	GGC	241;241;244	G;G;C	241;241;244	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2482	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1924	161.0	1	SNP	p	G45D	0	.	.	133	135	GGC	800	802	GGC	270;273;273	G;G;C	270;273;273	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1376	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1628	105.6	0	.	n	.	0	A197.	DEL	197	197	A	885	885	A	266	A	266	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	226.6	1	SNP	p	D86N	0	.	.	256	258	GAC	808	810	GAC	296;299;299	G,C;A,G;C	295,1;298,1;299	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	226.6	1	SNP	p	R87I	0	.	.	259	261	CGT	811	813	CGT	298;299;299	C,A,T;G;T	296,1,1;299;299	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	226.6	1	SNP	p	S87R	1	.	.	259	261	CGT	811	813	CGT	298;299;299	C,A,T;G;T	296,1,1;299;299	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	226.6	1	SNP	p	R87W	0	.	.	259	261	CGT	811	813	CGT	298;299;299	C,A,T;G;T	296,1,1;299;299	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	226.6	1	SNP	p	S88P	0	.	.	262	264	TCC	814	816	TCC	306;308;308	T;C;C	306;308;308	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5032	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3105	202.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1761	1763	GGC	288;283;280	G;G,T,C;C	288;281,1,1;280	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1574	1576	GCA	278;279;280	G;C;A	278;279;280	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1577	1579	ATC	281;283;286	A,T,C;T;C	279,1,1;283;286	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1589	1591	GTG	292;298;301	G;T,A;G,T	292;296,2;300,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1589	1591	GTG	292;298;301	G;T,A;G,T	292;296,2;300,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2093	2095	ACC	292;292;292	A,G;C,G;C,A	291,1;291,1;291,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2147	2149	GCG	263;265;266	G;C;G,C	263;265;265,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2147	2149	GCG	263;265;266	G;C;G,C	263;265;265,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2270	2272	AGC	269;267;263	A;G;C	269;267;263	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2279	2281	GGC	254;252;254	G;G;C	254;252;254	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4964	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3011	205.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2297	2299	CCG	270;270;274	C,G,T,A;C;G	266,2,1,1;270;274	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6646	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3624	228.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1938	1940	CCG	243;245;242	C;C;G	243;245;242	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3106	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2321	167.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	806	806	C	241	C	241	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	30;32;33	T;T;A	30;32;33	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	59;59;59	C;A;T	59;59;59	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	59;59;59	A;G;T	59;59;59	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	59;59;59	T;A,T;C	59;58,1;59	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	4;4;4	G;A;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	686	19.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	664	666	GAA	323;319;316	G;A;A,C	323;319;315,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	T119A	NONSYN	355	357	ACC	907	909	GCC	255;256;254	G,A;C;C	254,1;256;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	952	954	GAT	267;267;264	G;A;T,G	267;267;263,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1075	1077	TCA	313;316;317	T;C;A	313;316;317	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1204	1206	GTC	302;301;304	G;T;C,G	302;301;303,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1534	1536	GCA	295;296;301	G,T,A;C;A	293,1,1;296;301	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	1	SNP	p	G120K	1	.	.	358	360	AAG	910	912	AAG	254;257;256	A,G;A,G;G,A,T	252,2;256,1;253,2,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	1	SNP	p	A121D	1	.	.	361	363	GAC	913	915	GAC	256;259;261	G;A,C;C	256;258,1;261	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3432	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2009	213.0	1	SNP	p	D121N	0	.	.	361	363	GAC	913	915	GAC	256;259;261	G;A,C;C	256;258,1;261	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11528	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5432	265.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1844	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1470	156.1	1	SNP	p	V57M	1	.	.	169	171	ATG	761	763	ATG	320;320;320	A;T;G,C	320;320;319,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
